Pilot Study of Vedic Medicine for Type 2 Diabetes - Full Text View

Pilot Study of Vedic Medicine for Type 2 Diabetes

This study has been completed.

Sponsored by:	National Center for Complementary and Alternative Medicine (NCCAM)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00065650

Purpose

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

Condition	Intervention	Phase
Diabetes Mellitus, Type 2	Drug: Vedic Medicine Behavioral: Vedic Medicine	Phase II

MedlinePlus related topics:

Diabetes

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:	60
Study Start Date:	July 2003
Estimated Study Completion Date:	January 2004

Detailed Description:

Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.

Eligibility

Ages Eligible for Study:	25 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion criteria:

Kaiser Permanente members
Newly diagnosed type 2 Diabetes
Baseline glycosylated hemoglobin level of 6.0-7.9.

Exclusion criteria:

Pregnancy or nursing mother
Currently taking warfarin
Diagnosis of psychotic disorder or recent hospitalization for depression
Unable to comply with or attend treatment sessions

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00065650

Locations


United States, Oregon
	Kaiser Permanente Center for Health Research
	Portland, Oregon, United States, 97227

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

More Information

Publications:

Elder C. Application of the cooperative health care clinic model for the delivery of complementary/ alternative care. The Permanente Journal. Winter 2003; 7(1):55-60.

Elder C. Complementary and Alternative Medicine Symposium: Integrating CAM into clinical practice: The KP northwest story. The Permanente Journal, Fall 2002, 6(4):57-59

Study ID Numbers:	R21 AT001324-01
First Received:	July 30, 2003
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00065650
Health Authority:	United States: Federal Government

Keywords provided by National Center for Complementary and Alternative Medicine (NCCAM):

Diabetes Mellitus Type 2

Vedic medicine

Ayurveda

Transcendental Meditation

Study placed in the following topic categories:

Metabolic Diseases

Diabetes Mellitus, Type 2

Diabetes Mellitus

Endocrine System Diseases

Endocrinopathy

Metabolic disorder

Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on November 30, 2008